13D/13G Filings - ORBIMED CAPITAL LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
6:27 pm
Purchase
2024-09-30 13G SI-BONE, Inc.
SIBN
ORBIMED CAPITAL LLC 3,249,500
7.800%
944,200increase
(+40.96%)
Filing
History
2023-02-14
4:45 pm
Sale
2022-12-31 13G Milestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC 0
0.000%
-2,583,821decrease
(Position Closed)
Filing
History
2023-02-14
4:14 pm
Sale
2022-12-31 13G Cybin Inc.
CYBN
ORBIMED CAPITAL LLC 161,929
3.700%
-135,211decrease
(-45.50%)
Filing
History
2022-02-11
4:44 pm
Purchase
2021-12-31 13G SI-BONE, Inc.
SIBN
ORBIMED CAPITAL LLC 2,305,300
6.900%
2,305,300increase
(New Position)
Filing
History
2022-02-11
4:32 pm
Purchase
2021-12-31 13G Milestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC 2,583,821
8.700%
90,712increase
(+3.64%)
Filing
History
2022-02-11
4:20 pm
Purchase
2021-12-31 13G Cybin Inc.
CYBN
ORBIMED CAPITAL LLC 297,139
7.000%
297,139increase
(New Position)
Filing
History
2022-02-11
4:15 pm
Sale
2021-12-31 13G Aptose Biosciences Inc.
APTO
ORBIMED CAPITAL LLC 0
0.000%
-17,844decrease
(Position Closed)
Filing
History
2021-02-12
5:03 pm
Purchase
2020-12-31 13G Milestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC 2,493,109
8.360%
2,493,109increase
(New Position)
Filing
History
2021-02-12
4:42 pm
Purchase
2020-12-31 13G Aptose Biosciences Inc.
APTO
ORBIMED CAPITAL LLC 17,844
9.040%
17,844increase
(New Position)
Filing
History